Q1 FY25 results were within forecast range despite challenging market conditions, with consolidated net sales of $393M (down from $398M YoY), a 5% negative comp, and adjusted operating profit of $39M (9.8% margin vs. 14.4% prior year).
Lilly Pulitzer brand delivered double-digit sales growth with positive comps in both e-commerce and retail, driven by newness, strong product assortment, and focus on core customers; Tommy Bahama and Johnny Was segments saw sales declines, partially offset by new store openings.
Tariffs significantly impacted results: $1M in additional Q1 costs and a projected $40M gross impact for FY25, leading to an expected 200 bps gross margin contraction; company is accelerating supply chain diversification away from China (from 40% in 2024 to <10% in 2026) to mitigate future tariff exposure.
FY25 guidance updated: net sales expected between $1.475B–$1.515B (down 3% to flat YoY), adjusted EPS of $2.80–$3.20 (vs. $6.68 last year), with negative comps in the low to mid-single digits and gross margin contraction due to tariffs and increased promotional activity.
Capital expenditures for FY25 projected at ~$120M (mainly for new distribution center and store openings); company expects to remain in a net debt position for the year due to investments, share repurchases, and dividends, but anticipates strong operating cash flow in the second half.